Did Lisa McClain buy ImmunityBio stock?

Common questions

Did Lisa McClain buy ImmunityBio stock?

Yes. Lisa McClain disclosed 2 purchases of ImmunityBio (IBRX) stock between Sep 28, 2026 and Sep 30, 2026, in STOCK Act reports. Added together, the disclosed ranges come to $2K-$30K.

How big were Lisa McClain's ImmunityBio trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed ranges come to $2K-$30K.

Did Lisa McClain make these ImmunityBio trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Lisa McClain still own ImmunityBio stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Lisa McClain report these trades?

The latest filing is dated Oct 12, 2026. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.